Knok raises €4.4 million in funding round
The Nos 5G fund and Triple Point have co-led Knok's funding round. With the investment, the startup wants to move towards the new generation of mobile network technology.
Portugal-based startup Knok Healthcare closed a €4.4 million funding round, co-lead by Nos 5G Fund and Triple Point. With the money, the startup wants to move towards the new generation of mobile network technology and strengthen its presence in foreign markets.
With an initial capital of €10 million and an estimated investment period of five years, the 5G Nos Fund was the first in Portugal oriented towards the new mobile technology. Knok is the second Portuguese startup to receive an investment from this fund, after Reckon.ai.
José Bastos, CEO and co-founder of Knok, refers that the startup “enters a new phase of development after the closing of this funding round”. “The set of excellent investors we have gathered will contribute to accelerating the national and international expansion of our integrated health solution, reinforcing the presence in Spain, Brazil and other Latin American countries and reaching India, the UK and Italy,” he adds.
“On our path to being the digital gateway to healthcare, Nos is a key technology partner, and we are very excited to count on their support and know-how in 5G, which will allow us to take our product to another level, making it increasingly differentiated globally,” João Magalhães, CTO and co-founder of the startup, explains in a statement.
The startup’s technology allows video consultations, health data collection and scheduled appointments. Currently, Knok already serves over 2 million patients on four continents.
The company already has around 30 clients (among hospitals, clinics and insurance companies), a network of over 3,100 active doctors in nine specialities and, since the launch, has provided more than 160,000 consultations.
Knok was founded in 2015 by José Bastos and João Magalhães, with the goal of facilitating access to doctors through the use of an app.